Medical Developments International Ltd
ASX:MVP

Watchlist Manager
Medical Developments International Ltd Logo
Medical Developments International Ltd
ASX:MVP
Watchlist
Price: 0.49 AUD 1.03%
Market Cap: AU$55.2m

Operating Margin

-4.5%
Current
Improving
by 45.7%
vs 3-y average of -50.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4.5%
=
Operating Income
AU$-1.8m
/
Revenue
AU$39.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4.5%
=
Operating Income
AU$-1.8m
/
Revenue
AU$39.1m

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Medical Developments International Ltd
ASX:MVP
55.2m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...

Market Distribution

In line with most companies in Australia
Percentile
58th
Based on 3 951 companies
58th percentile
-4.5%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Medical Developments International Ltd
Glance View

Market Cap
55.2m AUD
Industry
Pharmaceuticals

Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The company is headquartered in Melbourne, Victoria and currently employs 68 full-time employees. The company went IPO on 2003-12-15. The firm is focused on manufacturing and distributing pharmaceutical drugs, and medical and veterinary equipment. The firm operates through three segments: Pharmaceuticals, Medical Devices and Veterinary Products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia, New Zealand, Europe and the United Kingdom, and some sales in the Middle East, Asia and South Africa. The Medical Devices segment is engaged in the sale of medical devices, particularly the Space Chamber and Breath-Alert PeakFlow meters, primarily within Australia, the United Kingdom/Europe, North America, and some sales in Asia and New Zealand. The Veterinary Products segment is engaged in the sale of veterinary products within Australia, Europe, and Asia.

MVP Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-4.5%
=
Operating Income
AU$-1.8m
/
Revenue
AU$39.1m
What is Medical Developments International Ltd's current Operating Margin?

The current Operating Margin for Medical Developments International Ltd is -4.5%, which is above its 3-year median of -50.2%.

How has Operating Margin changed over time?

Over the last 3 years, Medical Developments International Ltd’s Operating Margin has increased from -71.5% to -4.5%. During this period, it reached a low of -75% on Dec 31, 2023 and a high of -4.5% on Jun 30, 2025.

Back to Top